Oncternal Therapeutics Price on March 18, 2024

ONCTDelisted Stock  USD 0.53  0.00  0.00%   
If you're considering investing in Oncternal Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncternal Therapeutics stands at 0.53, as last reported on the 16th of December 2024, with the highest price reaching 0.53 and the lowest price hitting 0.53 during the day. Oncternal Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Oncternal Therapeutics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncternal Therapeutics' Variance of 154.07, coefficient of variation of (588.70), and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide.
  
Oncternal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1126

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsONCT

Estimated Market Risk

 10.87
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.22
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Oncternal Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncternal Therapeutics by adding Oncternal Therapeutics to a well-diversified portfolio.

Related Headline

Armata Pharmaceuticals Headline on 18th of March 2024

Filed transaction by Armata Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Oncternal Therapeutics Valuation on March 18, 2024

It is possible to determine the worth of Oncternal Therapeutics on a given historical date. On March 18, 2024 Oncternal was worth 7.82 at the beginning of the trading date compared to the closed value of 7.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncternal Therapeutics stock. Still, in general, we apply an absolute valuation method to find Oncternal Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncternal Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncternal Therapeutics' related companies.
 Open High Low Close Volume
  7.48    8.10    7.48    8.02    5,717  
03/18/2024
  7.82    8.31    7.80    7.80    18,254  
  7.80    7.90    7.80    7.88    1,625  
Backtest Oncternal Therapeutics  |  Oncternal Therapeutics History  |  Oncternal Therapeutics Valuation   PreviousNext  
Open Value
7.82
7.8
Closing Value
40.44
Upside

Oncternal Therapeutics Trading Date Momentum on March 18, 2024

On March 19 2024 Oncternal Therapeutics was traded for  7.88  at the closing time. The top price for the day was 7.90  and the lowest listed price was  7.80 . The trading volume for the day was 1.6 K. The trading history from March 19, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 1.03% . The trading delta at closing time against the current closing price is 3.08% .

Oncternal Therapeutics Fundamentals Correlations and Trends

By evaluating Oncternal Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncternal Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncternal financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oncternal Therapeutics Stock history

Oncternal Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncternal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncternal Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncternal Therapeutics stock prices may prove useful in developing a viable investing in Oncternal Therapeutics
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. Oncternal Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Oncternal Therapeutics Stock Technical Analysis

Oncternal Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Oncternal Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oncternal Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oncternal Therapeutics Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oncternal Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oncternal Therapeutics December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns

Oncternal Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oncternal Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Oncternal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncternal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Oncternal Stock

If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing